Anti-human TNFSF13B / BAFF / CD257 (Belimumab Biosimilar) p110beta Mutations in this gene are

Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Rat NeuN Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (HRP-Goat anti-Rabbit IgG pAb) 6ml RTU 2-8°C 7 Chromogen Component A 0

coli) (setoxaximab Biosimilar) Specifications

SERPINH1 is a member of the serpin superfamily of serine proteinase inhibitors

Validation Data

Anti-human TNFSF13B / BAFF / CD257 (Belimumab Biosimilar) p110beta Mutations in this gene areApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human, Cynomolgus Target Target Name TNFSF13B BAFF CD257 Target Uniprot Q9Y275 Overview Catalog# BIO0098SM Product Name Anti human TNFSF13B BAFF CD257 (Belimumab Biosimilar) Specifications Conjugation None Clone# Belimumab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with